Respiratory Symptoms
14
0
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (14)
A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms
Respiratory Muscle Training and Walking Exercise in Women Recovering From COVID-19 Pneumonia
Project PHOENIX: Molecular Signatures of Burn Pit Exposure
GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health
Work of Breathing Assessment in Triage Scale
A Population-based Investigation of Asthma in the Telemark Region of Norway
CoVID-19 Evaluation of Neurological and Autonomic Nervous System Troubles in Intensive Care Unit Patients
Evaluation of the Composition of Human Milk and Health Outcomes in Children
Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys
Work-related Respiratory Symptoms in Champagne Vineyard Workers
STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Belgian Pulmonary Function Study
GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)